Leptospirosis Vaccine Licensed for Use in Pregnant Mares

The USDA licensed a vaccine for use in pregnant mares to protect against leptospirosis, one cause of abortion in horses.
Share
Favorite
Close

No account yet? Register

ADVERTISEMENT

The U.S. Department of Agriculture has licensed an equine vaccine that protects against Leptospirosa pomona for use in broodmares during all three trimesters of pregnancy.

Leptospirosis, an infection of the L. pomona bacterium, can cause late-term abortion and recurrent uveitis in horses. The vaccine against leptospirosis, Lepto EQ Innovator, is manufactured and marketed by Zoetis.

Field safety studies, which examined the vaccine when used in the first, second, and third trimesters of pregnancy, showed no systemic or local reactions to vaccination.

A study showed that 13% of bacterial abortions are caused by L. pomona, the most common leptospiral serovar found in horses. Aborting mares have been reported to shed leptospires in their urine for periods up to three months and can transmit Leptospira to exposed animals. Some horses aborting due to leptospiral infection develop uveitis several weeks to months later. Additionally, the aborted fetus is a source of exposure to other horses on the property

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.

Share

Written by:

Related Articles

Stay on top of the most recent Horse Health news with

FREE weekly newsletters from TheHorse.com

Sponsored Content

Weekly Poll

sponsored by:

Where do you primarily feed your horse?
278 votes · 278 answers

Readers’ Most Popular

Sign In

Don’t have an account? Register for a FREE account here.

Need to update your account?

You need to be logged in to fill out this form

Create a free account with TheHorse.com!